Xiaofang Li

476 total citations
23 papers, 366 citations indexed

About

Xiaofang Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaofang Li has authored 23 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Xiaofang Li's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (5 papers). Xiaofang Li is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (5 papers). Xiaofang Li collaborates with scholars based in China and Australia. Xiaofang Li's co-authors include Yanmin Xia, Xiangjian Zhang, Yaoru Li, Tingting He, Xingyuan Zhu, Wei Cao, Lei Cui, Fan Yang, Xiuling Li and Lina Cheng and has published in prestigious journals such as Scientific Reports, Journal of Applied Ecology and Journal of Solid State Chemistry.

In The Last Decade

Xiaofang Li

21 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaofang Li China	8	190	129	57	45	35	23	366
Lifa Huang China	9	208 1.1×	112 0.9×	90 1.6×	22 0.5×	41 1.2×	21	399
Qin Hu China	8	257 1.4×	82 0.6×	64 1.1×	26 0.6×	59 1.7×	12	468
Jin Zhu China	10	234 1.2×	82 0.6×	118 2.1×	32 0.7×	40 1.1×	24	476
Chulei Deng China	8	224 1.2×	94 0.7×	52 0.9×	24 0.5×	53 1.5×	13	390
Boyang Wei China	12	219 1.2×	66 0.5×	74 1.3×	26 0.6×	78 2.2×	23	403
Juexian Song China	8	177 0.9×	127 1.0×	85 1.5×	26 0.6×	14 0.4×	18	355
Shengmei Zhu China	11	190 1.0×	149 1.2×	67 1.2×	12 0.3×	11 0.3×	20	361
Shizhong Zhang China	8	148 0.8×	46 0.4×	67 1.2×	38 0.8×	14 0.4×	20	308
Mingze Chang China	11	135 0.7×	43 0.3×	51 0.9×	23 0.5×	18 0.5×	20	264

Countries citing papers authored by Xiaofang Li

Since Specialization

Citations

This map shows the geographic impact of Xiaofang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Li more than expected).

Fields of papers citing papers by Xiaofang Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Li. The network helps show where Xiaofang Li may publish in the future.

Co-authorship network of co-authors of Xiaofang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Li. A scholar is included among the top collaborators of Xiaofang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Li. Xiaofang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Xiaobi, Xiaofang Li, Yongyang Chen, et al.. (2024). Suppression of the long non-coding RNA LINC01279 triggers autophagy and apoptosis in lung cancer by regulating FAK and SIN3A. Discover Oncology. 15(1). 3–3. 5 indexed citations

Wang, Qiong, Xiaofang Li, Xinhua Huang, et al.. (2024). Subtyping stage 3 epiretinal membrane: a comprehensive study of ectopic inner foveal layers architecture and its clinical implications. British Journal of Ophthalmology. 109(4). 476–481.

Rupakheti, Dipesh, et al.. (2024). Observational study of ultrafine particulate matter exposure under different commuting modes in a typical city of the Yangtze River Delta. Chinese Science Bulletin (Chinese Version). 70(22). 3659–3670. 1 indexed citations

Shang, Yanhong, Ran Huo, Xiaofang Li, et al.. (2023). Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients. Frontiers in Oncology. 12. 1064598–1064598. 1 indexed citations

Zhang, Hao, et al.. (2023). MiR-1278 targets CALD1 and suppresses the progression of gastric cancer via the MAPK pathway. Open Medicine. 18(1). 20230776–20230776. 3 indexed citations

Liang, Chengyu, et al.. (2021). Association of Parkinson’s Disease With Microbes and Microbiological Therapy. Frontiers in Cellular and Infection Microbiology. 11. 619354–619354. 36 indexed citations

Wang, Huiling, et al.. (2021). The value of serum procalcitonin in the anti-infection therapy of acute stroke patients. Pakistan Journal of Medical Sciences. 37(4). 1155–1160. 6 indexed citations

Li, Xiaofang, et al.. (2021). The control efficacy and mechanism of Talaromyces purpurogenus on Fusarium wilt of bitter gourd. Biological Control. 165. 104804–104804. 7 indexed citations

Li, Jinghua, et al.. (2020). Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation. The Oncologist. 25(10). 826–832. 3 indexed citations

10.

Yang, Wenchao, et al.. (2020). Distribution, diagnosis, and analysis of related risk factors of multidrug-resistant organism in patients with malignant neoplasms.. PubMed. 13(10). 2648–2655. 5 indexed citations

11.

Cui, Lei, Wei Cao, Yanmin Xia, & Xiaofang Li. (2020). Ulinastatin alleviates cerebral ischemia-reperfusion injury in rats by activating the Nrf-2/HO-1 signaling pathway. Annals of Translational Medicine. 8(18). 1136–1136. 31 indexed citations

12.

Yang, Fan, Xiaofang Li, Ling‐juan Zhang, Lina Cheng, & Xiuling Li. (2018). LncRNA TUG1 promoted viability and associated with gemcitabine resistant in pancreatic ductal adenocarcinoma. Journal of Pharmacological Sciences. 137(2). 116–121. 37 indexed citations

13.

Li, Xiaofang, Run Tian, Hugh Gao, et al.. (2017). Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients. Scientific Reports. 7(1). 16495–16495. 53 indexed citations

14.

Huang, Yu‐An, Zhu‐Hong You, Liping Li, et al.. (2017). EPMDA: an expression-profile based computational model for microRNA-disease association prediction. Oncotarget. 8(50). 87033–87043. 5 indexed citations

15.

Zang, Aimin, et al.. (2016). miRNA-486 and miRNA-499 in human plasma evaluate the clinical stages of lung cancer and play a role as a tumor suppressor in lung tumorigeneisis not pathogenesis. Bangladesh Journal of Pharmacology. 11(1). 264–264. 2 indexed citations

16.

Shang, Yanhong, Aimin Zang, Jinghua Li, et al.. (2016). MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Biomedicine & Pharmacotherapy. 83. 1175–1181. 27 indexed citations

17.

Pan, Li, Xiaofang Li, Xiangjian Zhang, et al.. (2015). Remote limb ischemic postconditioning protects mouse brain against cerebral ischemia/reperfusion injury via upregulating expression of Nrf2, HO-1 and NQO-1 in mice. International Journal of Neuroscience. 126(6). 1–8. 52 indexed citations

18.

Cai, Yun, et al.. (2015). Light-stimulated cargo release from a core–shell structured nanocomposite for site-specific delivery. Journal of Solid State Chemistry. 226. 179–185. 6 indexed citations

19.

Li, Xiaofang, et al.. (2014). Downregulation of olfactomedin 4 expression contributes to tumorigenesis of non-small cell lung cancer. International Journal of Clinical and Experimental Physiology. 1(2). 125–125. 2 indexed citations

20.

Li, Xiaofang, et al.. (2010). Changes of intestinal sIgA and mucin in mice with intestinal dysbacteria.. Zhongguo weishengtaixue zazhi. 22(6). 485–488. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact